The higher baseline levels of IP10, TARC, and EGF in the SU2043 group, coupled with the higher prevalence of asthma and atopic dermatitis, suggest that these comorbid conditions and associated biomarkers may reduce the likelihood of achieving SU. The gene discussed is CXCL10; the disease is atopic eczema.